Nymox Pharmaceutical Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
60.74 M |
Public Float |
31.09 M |
Nymox Pharmaceutical Corp. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.17 |
Market Cap |
$97.45 M |
Shares Outstanding |
67.68 M |
Public Float |
37.98 M |
Address |
Bay & Deveaux Streets Nassau NW Bahamas |
Employees | - |
Website | http://www.nymox.com |
Updated | 07/08/2019 |
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. |